| Literature DB >> 21731859 |
Abstract
The Nuremberg Code drafted at the end of the Doctor's trial in Nuremberg 1947 has been hailed as a landmark document in medical and research ethics. Close examination of this code reveals that it was based on the Guidelines for Human Experimentation of 1931. The resemblance between these documents is uncanny. It is unfortunate that the authors of the Nuremberg Code passed it off as their original work. There is evidence that the defendants at the trial did request that their actions be judged on the basis of the 1931 Guidelines, in force in Germany. The prosecutors, however, ignored the request and tried the defendants for crimes against humanity, and the judges included the Nuremberg Code as a part of the judgment. Six of ten principles in Nuremberg Code are derived from the 1931 Guidelines, and two of four newly inserted principles are open to misinterpretation. There is little doubt that the Code was prepared after studying the Guidelines, but no reference was made to the Guidelines, for reasons that are not known. Using the Guidelines as a base document without giving due credit is plagiarism; as per our understanding of ethics today, this would be considered unethical. The Nuremberg Code has fallen by the wayside; since unlike the Declaration of Helsinki, it is not regularly reviewed and updated. The regular updating of some ethics codes is evidence of the evolving nature of human ethics.Entities:
Keywords: Ethics; Nuremberg; guidelines; human subjects; research
Year: 2011 PMID: 21731859 PMCID: PMC3121268 DOI: 10.4103/2229-3485.80371
Source DB: PubMed Journal: Perspect Clin Res ISSN: 2229-3485
Comparison of the Nuremberg Code with the 1931 Guidelines
| The Nuremberg Code | 1931 Guidelines |
|---|---|
| 1. The voluntary consent of the human subject is absolutely essential. This means that the person involved should have legal capacity to give consent; should be situated as to be able to exercise free power of choice, without the intervention of any element of force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion, and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision. This latter element requires that before the acceptance of an affirmative decision by the experimental subject, there should be made known to him the nature, duration, and purpose of the experiment; the method and means by which it is to be conducted; all inconveniences and hazards reasonably to be expected; and the effects upon his health or person which may possibly come from his participation in the experiment. The duty and responsibility for ascertaining the quality of the consent rests upon each individual who initiates, directs, or engages in the experiment. It is a personal duty and responsibility which may not be delegated to another with impunity. | 5. Innovative therapy may be carried out only after the subject or his legal representative has unambiguously consented to the procedure in the light of relevant information provided in advance. Where consent is refused, innovative therapy may be initiated only if it constitutes an urgent rocedure to preserve life or prevent serious damage to health and prior consent could not be obtained under the circumstances. |
| 7. Exploitation of social hardship in order to undertake innovative therapy is incompatible with the principles of medical ethics. | |
| 2. The experiment should be such as to yield fruitful results for the good of society, unprocurable by other methods or means of study, and not random and unnecessary in nature. | 4. Any innovative therapy must be justified and performed in accordance with the principles of medical ethics and the rules of medical practice and theory. In all cases, the question of whether any adverse effects which may occur are proportionate to the anticipated benefits shall be examined and assessed. Innovative therapy may be carried out only if it has been tested in advance in animal trials (where these are possible). |
| 3. The experiment should be so designed and based on the results of animal experimentation and knowledge of the natural history of the disease or other problem under study that the anticipated results will justify the performance of the experiment. | (b) Experimentation involving human subjects shall be avoided if it can be replaced by animal studies. Experimentation involving human subjects may be carried out only after all data that can be collected by means of those biological methods (laboratory testing and animal studies) that are available to medical science for purposes of clarification and confirmation of the validity of the experiment have been obtained. Under these circumstances, motiveless and unplanned experimentation involving human subjects shall obviously be prohibited. |
| 4. The experiment should be so conducted as to avoid all unnecessary physical and mental suffering and injury. | Not covered by the 1931 Guidelines |
| 5. No experiment should be conducted where there is an a priori reason to believe that death or disabling injury will occur; except, perhaps, in those experiments where the experimental physicians also serve as subjects. | |
| 6. The degree of risk to be taken should never exceed that determined by the humanitarian importance of the problem to be solved by the experiment. | Risk benefit analysis covered under Point 4 of the guidelines |
| 7. Proper preparations should be made and adequate facilities provided to protect the experimental subject against even remote possibilities of injury disability or death. | Not covered by the 1931 Guidelines |
| 8. The experiment should be conducted only by scientifically qualified persons. The highest degree of skill and care should be required through all stages of the experiment of those who conduct or engage in the experiment. | 9. In clinics, policlinics, hospitals, or other treatment and care establishments, innovative therapy may be carried out only by the physician in charge or by another physician acting in accordance with his express instructions and subject to his complete responsibility. |
| 9. During the course of the experiment, the human subject should be at liberty to bring the experiment to an end if he has reached the physical or mental state where continuation of the experiment seems to him to be impossible. | Not covered by the 1931 Guidelines |
| 10. During the course of the experiment, the scientist in charge must be prepared to terminate the experiment at any stage, if he has probable cause to believe, in the exercise of the good faith, superior skill, and careful judgment required by him that a continuation of the experiment is likely to result in injury, disability, or death to the experimental subject. | Not covered by the 1931 Guidelines |